Intrinsiqq
Teladoc Health Inc. logo

Teladoc Health Inc. (TDOC) Insider Trading

Last 12 months

Insiders bought $69k and sold $2.39M on the open market.

21% of the selling was scheduled in advance under 10b5-1 plans. CHIEF EXECUTIVE OFFICER Charles Divita III sold $257k on Mar 2, 13% of their stake, outside a plan.

Net open-market
−$2.32M
1 buy · 34 sales
Under a 10b5-1 plan
21%
of the value sold
Insiders who bought / sold
1 / 6
executives and directors
Last open-market buy
Nov 2025
Nov 14, 2025

Get an email when TDOC's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 2No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 655 at $5.65
    $4k
    4.4% of stake
  • Sep 11No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 17,805 at $6.10
    $109k
    3.7% of stake
  • Sep 2 – 310b5-1 plan
    Fernando M. Rodrigues
    President of BetterHelp · sold 15,251 at avg $6.44
    $98k
    100% of stake
  • Sep 2No plan
    Carlos Nueno
    President, International · sold 6,200 at $6.30
    $39k
    8.7% of stake
  • Sep 2No plan
    Kelly Bliss
    President, U.S. Group Health · sold 7,357 at $6.30
    $46k
    7.3% of stake
  • Sep 2No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 274 at $6.30
    $2k
    2.1% of stake
  • Sep 2No plan
    Adam C Vandervoort
    CHIEF LEGAL OFFICER, SECRETARY · sold 7,573 at $6.30
    $48k
    6.0% of stake
  • Sep 2No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 18,327 at $6.30
    $115k
    4.0% of stake
  • Jul 610b5-1 plan
    Kelly Bliss
    President, U.S. Group Health · sold 2,500 at $9.50
    $24k
    2.9% of stake
  • Jul 2No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 653 at $9.10
    $6k
    5.1% of stake
  • Jul 110b5-1 plan
    Kelly Bliss
    President, U.S. Group Health · sold 2,500 at $9.00
    $23k
    2.8% of stake
  • Jun 2910b5-1 plan
    Kelly Bliss
    President, U.S. Group Health · sold 2,500 at $8.50
    $21k
    2.7% of stake
  • Jun 11No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 18,074 at $6.94
    $125k
    4.2% of stake
  • Jun 310b5-1 plan
    Fernando M. Rodrigues
    President of BetterHelp · sold 9,572 at $7.40
    $71k
    100% of stake
  • Jun 2No plan
    Carlos Nueno
    President, International · sold 6,196 at $7.63
    $47k
    9.7% of stake
  • Jun 2No plan
    Fernando M. Rodrigues
    President of BetterHelp · sold 5,677 at $7.63
    $43k
    37% of stake
  • Jun 2No plan
    Kelly Bliss
    President, U.S. Group Health · sold 7,679 at $7.63
    $59k
    7.7% of stake
  • Jun 2No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 284 at $7.63
    $2k
    2.6% of stake
  • Jun 2No plan
    Adam C Vandervoort
    CHIEF LEGAL OFFICER, SECRETARY · sold 7,906 at $7.63
    $60k
    6.7% of stake
  • Jun 2No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 19,132 at $7.63
    $146k
    4.7% of stake
  • Apr 2No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 675 at $5.11
    $3k
    6.2% of stake
  • Mar 11No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 27,731 at $5.49
    $152k
    7.1% of stake
  • Mar 2 – 310b5-1 plan
    Fernando M. Rodrigues
    President of BetterHelp · sold 41,400 at avg $5.04
    $208k
    100% of stake
  • Mar 2No plan
    Carlos Nueno
    President, International · sold 20,165 at $5.12
    $103k
    28% of stake
  • Mar 2No plan
    Kelly Bliss
    President, U.S. Group Health · sold 26,647 at $5.12
    $136k
    24% of stake
  • Mar 2No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 1,333 at $5.12
    $7k
    13% of stake
  • Mar 2No plan
    Adam C Vandervoort
    CHIEF LEGAL OFFICER, SECRETARY · sold 27,083 at $5.12
    $139k
    21% of stake
  • Mar 2No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 50,145 at $5.12
    $257k
    13% of stake
  • Jan 5No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 758 at $7.15
    $5k
    10% of stake
  • Dec 11, 2025No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 17,138 at $7.63
    $131k
    7.9% of stake
  • Dec 2, 2025 – Dec 3, 202510b5-1 plan
    Fernando M. Rodrigues
    President of BetterHelp · sold 6,533 at avg $7.48
    $49k
    100% of stake
  • Dec 2, 2025No plan
    Carlos Nueno
    President, International · sold 3,897 at $7.49
    $29k
    13% of stake
  • Dec 2, 2025No plan
    Kelly Bliss
    President, U.S. Group Health · sold 4,582 at $7.49
    $34k
    7.1% of stake
  • Dec 2, 2025No plan
    Adam C Vandervoort
    CHIEF LEGAL OFFICER, SECRETARY · sold 5,720 at $7.49
    $43k
    6.6% of stake
  • Nov 14, 2025
    Kenneth H Paulus
    Director · bought 10,000 at $6.94
    $69k
    New position
  • Oct 2, 2025No plan
    Joseph Ronald Catapano
    Chief Accounting Officer · sold 2,972 at $7.89
    $23k
    36% of stake
  • Sep 11, 2025No plan
    Charles Divita III
    CHIEF EXECUTIVE OFFICER · sold 16,787 at $7.59
    $127k
    8.6% of stake
  • Sep 2, 2025 – Sep 3, 202510b5-1 plan
    Fernando M. Rodrigues
    President of BetterHelp · sold 6,532 at avg $7.59
    $50k
    100% of stake
  • Sep 2, 2025No plan
    Carlos Nueno
    President, International · sold 3,998 at $7.59
    $30k
    15% of stake
  • Sep 2, 2025No plan
    Adam C Vandervoort
    CHIEF LEGAL OFFICER, SECRETARY · sold 5,867 at $7.59
    $45k
    7.2% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TDOC, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Services-Offices & Clinics of Doctors of Medicine

Spot a number that looks wrong? Check it in TDOC's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TDOC

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.